The association between participation in a pay-for-performance program and macrovascular complications in patients with type 2 diabetes in Taiwan: A nationwide population-based cohort study

Preventive Medicine

Volumn 85, Issue , 2016, Pages 53-59

  Hsieh, Hui Min ^a   Lin, Tsung Hsien ^b,c   Lee, I Chen ^a   Huang, Chun Jen ^b,c   Shin, Shyi Jang ^a,c   Chiu, Herng Chia ^a,d  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Diabetes care; Disease management; Macrovascular complications; Pay for performance; Preventive care

Indexed keywords

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DISEASE SEVERITY; FEMALE; GANGRENE; HEALTH PROGRAM; HEART FAILURE; HEART INFARCTION; HUMAN; LEG ULCER; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PAY FOR PERFORMANCE PROGRAM; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; TAIWAN; CARDIOVASCULAR DISEASES; COMPLICATION; DISEASE MANAGEMENT; ECONOMICS; INCIDENCE; INSURANCE; OUTCOME ASSESSMENT; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; PUBLIC HEALTH; REIMBURSEMENT; STANDARDS; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; FEMALE; HUMANS; INCIDENCE; INSURANCE CLAIM REVIEW; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; OUTCOME ASSESSMENT (HEALTH CARE); PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; REIMBURSEMENT, INCENTIVE; RISK REDUCTION BEHAVIOR; TAIWAN;

EID: 84955464153     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2015.12.013     Document Type: Article

References (45)

1. Alshamsan R., Millett C., Majeed A., Khunti K. Has pay for performance improved the management of diabetes in the United Kingdom?. Prim. Care Diab. 2010, 4:73-78.
2. Andersen R.M. Revisiting the behavioral model and access to medical care: does it matter?. J. Health Soc. Behav. 1995, 36:1-10.
3. American Diabetes Association Standards of medical care in diabetes-2014. Diabetes Care 2014, 37:S14-S80.
4. Austin P.C. The performance of different propensity-score methods for estimating relative risks. J. Clin. Epidemiol. 2008, 61:537-545.
5. Bayliss E.A., Bhardwaja B., Ross C., Beck A., Lanese D.M. Multidisciplinary team care may slow the rate of decline in renal function. Clin. J. Am. Soc. Nephrol.: CJASN 2011, 6:704-710.
6. Boyd C.M., Darer J., Boult C., Fried L.P., Boult L., Wu A.W. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA: J. Am. Med. Assoc. 2005, 294:716-724.
7. Campbell S.M., Reeves D., Kontopantelis E., Sibbald B., Roland M. Effects of pay for performance on the quality of primary care in England. N. Engl. J. Med. 2009, 361:368-378.
8. Chen J.Y., Tian H., Juarez D.T., et al. Does pay for performance improve cardiovascular care in a "real-world" setting?. Am. J. Med. Qual.: Off. J. Am. Coll. Med. Qual. 2011, 26:340-348.
9. Chen P.C., Lee Y.C., Kuo R.N. Differences in patient reports on the quality of care in a diabetes pay-for-performance program between 1year enrolled and newly enrolled patients. Int. J. Qual. Health Care: J. Int. Soc. Qual. Health Care/ ISQua 2012, 24:189-196.
10. Chen C.C., Tseng C.H., Cheng S.H. Continuity of care, medication adherence, and health care outcomes among patients with newly diagnosed type 2 diabetes: a longitudinal analysis. Med. Care 2013, 51:231-237.
11. Cheng S.H., Lee T.T., Chen C.C. A longitudinal examination of a pay-for-performance program for diabetes care: evidence from a natural experiment. Med. Care 2012, 50:109.
12. Cheng J.S., Tsai W.C., Lin C.L., et al. Trend and factors associated with healthcare use and costs in type 2 diabetes mellitus: a decade experience of a universal health insurance program. Med. Care 2015, 53:116-124.
13. Dehejia R.H., Wahba S. Propensity score-matching methods for nonexperimental causal studies. Rev. Econ. Stat. 2002, 84:151-161.
14. Deshpande A.D., Harris-Hayes M., Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys. Ther. 2008, 88:1254-1264.
15. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J. Clin. Epidemiol. 1992, 45:613-619.
16. Diabetes Prevention Program Outcomes Study Research, G., Orchard T.J., Temprosa M., et al. Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP outcomes study. Diabet. Med.: J. Br. Diabet. Assoc. 2013, 30:46-55.
17. Doran T., Kontopantelis E. Pay-for-performance: impact on diabetes. Curr. Diab. Rep. 2013, 13:196-204.
18. Duckworth W., Abraira C., Moritz T., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 2009, 360:129-139.
19. Fowler M.J. Microvascular and macrovascular complications of diabetes. Clin. Diab. 2008, 26:77-82.
20. Glickman S.W., Ou F.S., DeLong E.R., et al. Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA: J. Am. Med. Assoc. 2007, 297:2373-2380.
21. Greene J. An examination of pay-for-performance in general practice in Australia. Health Serv. Res. 2013, 48:1415-1432.
22. Gregg E.W., Li Y., Wang J., et al. Changes in diabetes-related complications in the United States, 1990-2010. N. Engl. J. Med. 2014, 370:1514-1523.
23. Halanych J.H., Safford M.M., Keys W.C., et al. Burden of comorbid medical conditions and quality of diabetes care. Diabetes Care 2007, 30:2999-3004.
24. Harvey R., Jankus D.D., Mosley D. Random assignment of proxy event dates to unexposed individuals in observational studies: An automated technique using SAS 2012, Available at, (Assessed date: Nov 12, 2014). http://www.mwsug.org/proceedings/2012/PH/MWSUG-2012-PH02.pdf.
25. Hsieh H.M., Tsai S.L., Shin S.J., Mau L.W., Chiu H.C. Cost-effectiveness of diabetes pay-for-performance incentive designs. Med. Care 2015, 53:106-115.
26. IDF International Diabetes Federation (IDF) Diabetes ATLAS 2014, Available at, (Assessed date: April 17, 2015). http://www.idf.org/sites/default/files/Atlas-poster-2014_EN.pdf, sixth ed.
27. Kent D., D'Eramo Melkus G., Stuart P.M., et al. Reducing the risks of diabetes complications through diabetes self-management education and support. Popul. Health Manag. 2013, 16:74-81.
28. Knight K., Badamgarav E., Henning J.M., et al. A systematic review of diabetes disease management programs. Am. J. Manag. Care 2005, 11:242-250.
29. Lai C.L., Hou Y.H. The association of clinical guideline adherence and pay-for-performance among patients with diabetes. J. Chin. Med. Assoc.: JCMA 2013, 76:102-107.
30. Lee T.T., Cheng S.H., Chen C.C., Lai M.S. A pay-for-performance program for diabetes care in Taiwan: a preliminary assessment. Am. J. Manag. Care 2010, 16:65-69.
31. Nickerson H.D., Dutta S. Diabetic complications: current challenges and opportunities. J. Cardiovasc. Transl. Res. 2012, 5:375-379.
32. O'Keefe J.H., Abuannadi M., Lavie C.J., Bell D.S. Strategies for optimizing glycemic control and cardiovascular prognosis in patients with type 2 diabetes mellitus. Mayo Clin. Proc. 2011, 86:128-138.
33. Petrea R.E., Beiser A.S., Seshadri S., Kelly-Hayes M., Kase C.S., Wolf P.A. Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke; J. Cereb. Circ. 2009, 40:1032-1037.
34. Pham H.H., Schrag D., O'Malley A.S., Wu B., Bach P.B. Care patterns in Medicare and their implications for pay for performance. N. Engl. J. Med. 2007, 356:1130-1139.
35. Pimouguet C., Le Goff M., Thiebaut R., Dartigues J.F., Helmer C. Effectiveness of disease-management programs for improving diabetes care: a meta-analysis. CMAJ: Can. Med. Assoc. J.= J. Assoc. Med. Can. 2011, 183:E115-E127.
36. Quan H., Li B., Couris C.M., et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am. J. Epidemiol. 2011, 173:676-682.
37. Rosenthal M.B., Frank R.G., Li Z., Epstein A.M. Early experience with pay-for-performance: from concept to practice. JAMA: J. Am. Med. Assoc. 2005, 294:1788-1793.
38. Ryan A.M., Doran T. The effect of improving processes of care on patient outcomes: evidence from the United Kingdom's quality and outcomes framework. Med. Care 2012, 50:191-199.
39. Tapp H., Phillips S.E., Waxman D., Alexander M., Brown R., Hall M. Multidisciplinary team approach to improved chronic care management for diabetic patients in an urban safety net ambulatory care clinic. J. Am. Board Fam. Med.:JABFM 2012, 25:245-246.
40. Tricco A.C., Ivers N.M., Grimshaw J.M., et al. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet 2012, 379:2252-2261.
41. Tu S.T., Chang S.J., Chen J.F., et al. Prevention of diabetic nephropathy by tight target control in an Asian population with type 2 diabetes mellitus: a 4-year prospective analysis. Arch. Intern. Med. 2010, 170:155-161.
42. Turnbull F.M., Abraira C., Anderson R.J., et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009, 52:2288-2298.
43. Vaghela P., Ashworth M., Schofield P., Gulliford M.C. Population intermediate outcomes of diabetes under pay-for-performance incentives in England from 2004 to 2008. Diabetes Care 2009, 32:427-429.
44. Yeh R.W., Sidney S., Chandra M., Sorel M., Selby J.V., Go A.S. Population trends in the incidence and outcomes of acute myocardial infarction. N. Engl. J. Med. 2010, 362:2155-2165.
45. Young B.A., Lin E., Von Korff M., et al. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am. J. Manag. Care 2008, 14:15-23.